Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on 2026-06-25. The reported weighted-average price was $5.50 per share, for total proceeds of $27,525. This was a sale — often routine insider selling — executed pursuant to a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-06-25; filing date: 2026-06-26 (filed promptly).
• Type: Sale (S), described as open market or private sale in the Form 4.
• Price: weighted average $5.50; sales occurred at prices ranging from $5.30 to $5.69 (Reporting Person can provide per-price breakdown on request) — see footnote.
• Total proceeds: $27,525.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Notable footnotes: F1 indicates the trade was made under a duly adopted Rule 10b5-1(c) trading plan; F2 explains the weighted-average price and price range.

Context

• A 10b5-1 plan means the trades were pre-authorized and generally planned in advance, which can make them more routine and less indicative of new inside information. Sales do not necessarily signal negative views; they may reflect personal liquidity or diversification needs.